Compare Arbitrum (ARB) vs Injective (INJ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Arbitrum vs Injective — how do they compare? Arbitrum trades at Rp1,376 (market cap Rp8,76T, Rp1,08T 24h volume), while Injective trades at Rp83,895 (market cap Rp8,37T, Rp1,26T 24h volume). The key difference: Arbitrum and Injective are close in size by market cap, and Arbitrum's circulating supply is 6,4B ARB versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 61 Days and Injective for 36 Days on average.
| ARB | INJ | |
|---|---|---|
Market Cap | Rp8,76T | Rp8,37T |
Volume (24h) | Rp1,08T | Rp1,26T |
Circulating Supply | 6,4B ARB | 100M INJ |
Typical Hold Time | 61 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Arbitrum is trading at Rp1,371 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The current price sits below the pivot point of Rp1,402, with immediate support at Rp1,354. Recent ecosystem news includes Pheasant Network's $2 million seed round to advance AI-powered cross-chain technology, potentially benefiting Arbitrum's DeFi ecosystem.
Overall outlook is cautious due to bearish technicals, but network growth and AI integration developments offer long-term opportunities. Key risks include high volatility, regulatory uncertainty, and reliance on Ethereum's ecosystem. Investors should monitor support levels and on-chain activity for signs of trend reversal.
INJ is trading at Rp83,360 with a market cap of Rp8.39T, showing neutral technical signals overall. The asset is currently positioned between key support at Rp82,799 and resistance at Rp86,949, with mixed moving average signals but neutral oscillators. Recent network activity shows an average hold time of 36 days, indicating moderate holding behavior among investors.
Outlook remains cautiously neutral with potential for movement toward resistance levels. Key opportunities include protocol ecosystem growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor volume patterns and network adoption metrics for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Arbitrum
Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.
Read more on ARB →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
